3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
4
Urinary Bladder Neoplasms
2
Small Cell Lung Carcinoma
2
Precancerous Conditions
2
Lung Neoplasms
2
Vascular Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Neurotoxicity Syndromes
1
Neoplasms
1
Myocardial Ischemia
1
Myocardial Infarction
1
Heart Diseases
1
Head and Neck Neoplasms
1
Depression
1
Delirium
1
Coronary Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cerebrovascular Disorders
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Adenomatous Polyps
1
Interventions
Vorinostat
1
Vitamin E
1
Bortezomib
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Vascular Diseases
×
Vitamin E
×
Clear all
NCT00000479
2012-06-15
WHS
Brigham and Women's Hospital
Phase 3
Completed
39,876 enrolled
11 charts